• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant.胎粪对外源性肺表面活性物质物理表面性质及形态的体外效应
J Korean Med Sci. 1996 Oct;11(5):429-36. doi: 10.3346/jkms.1996.11.5.429.
2
Morphology and function of pulmonary surfactant inhibited by meconium.
Pediatr Res. 1998 Aug;44(2):187-91. doi: 10.1203/00006450-199808000-00008.
3
Inhibitory effect of meconium on pulmonary surfactant function tested in vitro using the stable microbubble test.使用稳定微泡试验在体外测试胎粪对肺表面活性物质功能的抑制作用。
Eur J Pediatr. 2000 Oct;159(10):770-4. doi: 10.1007/pl00008344.
4
Current strategy for management of meconium aspiration syndrome.胎粪吸入综合征的当前管理策略。
Acta Paediatr Taiwan. 2000 Sep-Oct;41(5):241-5.
5
Inhibition of pulmonary surfactant function by meconium.胎粪对肺表面活性物质功能的抑制作用。
Am J Obstet Gynecol. 1991 Feb;164(2):477-81. doi: 10.1016/s0002-9378(11)80003-7.
6
Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome.基于重组表面活性蛋白C的表面活性剂对胎粪吸入综合征模型中肺功能和肺表面活性剂系统的影响。
Crit Care Med. 2006 Jan;34(1):203-10. doi: 10.1097/01.ccm.0000190624.77908.e2.
7
How to overcome surfactant dysfunction in meconium aspiration syndrome?如何克服胎粪吸入综合征中的表面活性剂功能障碍?
Respir Physiol Neurobiol. 2013 Jun 1;187(1):58-63. doi: 10.1016/j.resp.2013.02.030. Epub 2013 Mar 5.
8
Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.胎粪通过胆固醇和胆汁酸的共同作用损害肺表面活性剂。
Biophys J. 2011 Feb 2;100(3):646-655. doi: 10.1016/j.bpj.2010.12.3715.
9
Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study.
Acta Paediatr. 2001 Apr;90(4):412-6.
10
Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of gram-negative bacteria in vitro.多粘菌素B/肺表面活性物质混合物增强了对胎粪灭活的抵抗力,并在体外减少革兰氏阴性菌的生长。
Pediatr Res. 2006 Mar;59(3):407-11. doi: 10.1203/01.pdr.0000200806.32822.e6.

引用本文的文献

1
Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin.抑制和拮抗天然来源的临床肺表面活性剂——表面活性物质。
PLoS One. 2018 Sep 20;13(9):e0204050. doi: 10.1371/journal.pone.0204050. eCollection 2018.
2
Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.胎粪通过胆固醇和胆汁酸的共同作用损害肺表面活性剂。
Biophys J. 2011 Feb 2;100(3):646-655. doi: 10.1016/j.bpj.2010.12.3715.

胎粪对外源性肺表面活性物质物理表面性质及形态的体外效应

In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant.

作者信息

Park K H, Bae C W, Chung S J

机构信息

Department of Pediatrics, Masan Samsung Hospital, Asan Medical Center, Masan, Seoul, Korea.

出版信息

J Korean Med Sci. 1996 Oct;11(5):429-36. doi: 10.3346/jkms.1996.11.5.429.

DOI:10.3346/jkms.1996.11.5.429
PMID:8934399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3054187/
Abstract

The pathophysiology of meconium aspiration syndrome(MAS) is related to mechanical obstruction of the airways and to chemical pneumonitis. Meconium is also suggested to cause functional deterioration of pulmonary surfactant. Recent studies have reported that meconium inhibits the physical surface properties of pulmonary surfactant, and that administration of exogenous surfactant may provide therapeutic benefits in animal models or infants with respiratory distress due to MAS. To assess the effects of meconium on physical surface properties, especially the changes on the air-liquid interface and hypophase of pulmonary surfactant in vitro, we studied the following findings; a) the surface spreading rate(SSR) and the surface adsorption rate(SAR), b) the viscosity, c) the electron microscopic changes, on a series of mixtures with various concentrations of lyophilized human meconium and Surfactant-TA(SurfactenTM). The human meconium has significantly increased the surface tension of SSR and the viscosity of pulmonary surfactant, but had decreased the surface pressure of SAR of surfactant, and changed the electron microscopic findings of surfactant. We have concluded that these findings support the concept that meconium-induced surfactant dysfunction may play a role in the pathophysiology of MAS.

摘要

胎粪吸入综合征(MAS)的病理生理学与气道机械性阻塞和化学性肺炎有关。胎粪也被认为会导致肺表面活性物质功能恶化。最近的研究报告称,胎粪会抑制肺表面活性物质的物理表面特性,并且外源性表面活性物质的给药可能对因MAS导致呼吸窘迫的动物模型或婴儿具有治疗益处。为了评估胎粪对物理表面特性的影响,特别是在体外对肺表面活性物质气液界面和亚相的影响,我们研究了以下结果:a)表面铺展速率(SSR)和表面吸附速率(SAR),b)粘度,c)电子显微镜下的变化,针对一系列含有不同浓度冻干人胎粪和表面活性物质TA(SurfactenTM)的混合物。人胎粪显著增加了SSR的表面张力和肺表面活性物质的粘度,但降低了表面活性物质SAR的表面压力,并改变了表面活性物质的电子显微镜观察结果。我们得出结论,这些结果支持以下观点,即胎粪诱导的表面活性物质功能障碍可能在MAS的病理生理学中起作用。